Market Risers: Halma plc, GlaxoSmithKline plc, AstraZeneca plc, Bunzl plc, Compass Group plc & Intertek Group plc

Halma Plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Shares of Halma plc company symbol: LON:HLMA has stepped up 4.27% or 56 points throughout today’s trading session so far. Traders have so far held a positive outlook throughout the trading session. The periods high figure was 1386 meanwhile the session low reached 1343. Volume total for shares traded during this period was 468,295 whilst the average number of shares exchanged is 1,453,704. The 52 week high price for the shares is 1507.97 about 196.97 points difference from the previous days close and putting the 52 week low at 1136 a difference of some 175 points. Halma plc now has a 20 SMA at 1327.75 and now its 50 day moving average now at 1366.26. Market capitalisation is now £5,185.96m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Halma plc being recorded at Tuesday, November 20, 2018 at 12:03:08 PM GMT with the stock price trading at 1367 GBX.

 

Shares of GlaxoSmithKline plc with ticker code: LON:GSK has moved up 1.19% or 18.6 points in today’s trading session so far. Buyers have remained positive during the session. The periods high figure was 1589.6 dropping as low as 1566.6. The total volume of shares exchanged so far has reached 1,964,138 with the daily average at 10,395,230. A 52 week share price high is 1631.13 which comes in at 62.53 points difference from the previous days close and putting the 52 week low at 1179.39 making a difference of 389.21 points. GlaxoSmithKline plc now has a 20 simple moving average of 1555.86 and now the 50 day simple moving average now of 1533.26. The market capitalisation currently stands at £78,835.00m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for GlaxoSmithKline plc being recorded at Tuesday, November 20, 2018 at 12:03:30 PM GMT with the stock price trading at 1587.2 GBX.

 

Shares of AstraZeneca plc with EPIC code: LON:AZN has risen 1.47% or 91 points during the course of today’s session so far. Market buyers have stayed positive during the trading session. Range high for the period has seen 6319 and a low of 6200. The number of shares traded by this point in time totalled 745,916 with the average number of shares traded daily being 2,819,077. The 52 week high for the shares is 6432.48 which is 258.48 points difference from the previous close and the 52 week low at 4544.5 a difference of some 1629.5 points. AstraZeneca plc now has a 20 SMA at 6076.4 and the 50 day simple moving average now of 5923.16. The market capitalisation currently stands at £79,364.91m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Tuesday, November 20, 2018 at 12:03:30 PM GMT with the stock price trading at 6265 GBX.

 

Stock in Bunzl plc ticker code: LON:BNZL has stepped up 1.44% or 33 points in today’s trading session so far. Investors have remained optimistic throughout the session. The high for the period has peaked at 2332 and a low of 2283. The total volume traded so far comes to 168,101 whilst the daily average number of shares exchanged is just 1,417,450. The 52 week high price for the shares is 2442 around 148 points difference from the previous days close and the 52 week low at 1918.5 is a variance of 375.5 points. Bunzl plc now has a 20 simple moving average of 2289.5 and now its 50 day moving average of 2328.78. The current market capitalisation is £7,827.87m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Bunzl plc being recorded at Tuesday, November 20, 2018 at 12:03:21 PM GMT with the stock price trading at 2327 GBX.

 

Shares of Compass Group plc EPIC code: LON:CPG has risen 3.87% or 61.5 points throughout the session so far. Traders have stayed positive during the session. The periods high figure was 1669 dipping to 1614. The total volume traded so far comes to 1,530,034 with the daily average at 4,278,789. The 52 week high for the shares is 1722 about 134.5 points in difference on the previous days close and a 52 week low being 1396.5 making a difference of 191 points. Compass Group plc now has a 20 simple moving average of 1559.88 and also a 50 day simple moving average now of 1599.93. The market capitalisation currently stands at £26,121.27m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Compass Group plc being recorded at Tuesday, November 20, 2018 at 12:03:00 PM GMT with the stock price trading at 1649 GBX.

 

The trading price for Intertek Group plc with ticker code: LON:ITRK has increased 1.84% or 83 points in today’s trading session so far. Investors seem confident during this period. The period high was 4610 while the low for the session was 4478. The total volume of shares exchanged so far has reached 103,802 whilst the average number of shares exchanged is 592,573. A 52 week share price high is 6084 equating to 1568 points different to the previous business close and a 52 week low sitting at 4323 a difference of some 193 points. Intertek Group plc now has a 20 moving average of 4631.5 and now a 50 day moving average at 4746.98. Market capitalisation for the company is £7,422.47m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Intertek Group plc being recorded at Tuesday, November 20, 2018 at 12:03:15 PM GMT with the stock price trading at 4599 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    AstraZeneca Plc commits $3.5 billion to boost US research and manufacturing by 2026, creating jobs and expanding its innovation footprint.
    AstraZeneca and Amgen's Tezspire shows promise in reducing nasal polyp size and congestion, offering hope for chronic rhinosinusitis patients.
    GSK Plc reports Q3 2024 results with strong growth in Specialty Medicines offsetting lower Vaccine sales. Core earnings rose by 5%, despite Zantac charges.
    AstraZeneca's Wainzua gains CHMP backing for EU approval in treating ATTRv-PN, marking a potential breakthrough with self-administered therapy.
    GSK's new antibiotic gepotidacin earns FDA's Priority Review, marking potential first new uUTI oral treatment in 20 years, with decision due March 2025.

      Search

      Search